Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
28-Oct-2024
Global
Frost Radar
PFP2-01-00-00-00
HC_2024_1089
$4,950.00
Special Price $4,207.50 save 15 %
With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare providers using scientific data and testimonials. Pharma companies collaborate with third-party logistics providers and adopt adaptive supply chain strategies such as dual sourcing, stockpiling, and advanced scenario planning while tapping the capabilities of established distribution partners to avoid risks and disruptions.
Clearly defined marketing and sales strategies allow pharma companies to navigate regulatory bodies, end-user segments, and other technology vendors.
This Frost Radar™ includes companies that provide cutting-edge solutions and services across the commercialization value chain. The focus areas include supporting managed markets with respect to market access strategies, using AI/ ML-enabled platforms, and omnichannel marketing and sales strategies. Most profiled companies have a global presence.
Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.
Strategic Imperative
Strategic Imperative (continued)
Growth Environment
Growth Environment (continued)
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
Frost Radar™ Competitive Environment
Frost Radar™ Competitive Environment (continued)
Frost Radar™ Competitive Environment (continued)
Frost Radar™ Competitive Environment (continued)
Aktana
Aktana (continued)
Aktana (continued)
Aktana (continued)
Axtria
Axtria (continued)
Axtria (continued)
EVERSANA
EVERSANA (continued)
EVERSANA (continued)
EVERSANA (continued)
iNIZIO
iNIZIO (continued)
iNIZIO (continued)
IQVIA
IQVIA (continued)
IQVIA (continued)
OPEN Health
OPEN Health (continued)
OPEN Health (continued)
OPEN Health (continued)
Syneos Health
Syneos Health (continued)
Syneos Health (continued)
Syneos Health (continued)
Syneos Health (continued)
Trinity Life Sciences
Trinity Life Sciences (continued)
Trinity Life Sciences (continued)
Trinity Life Sciences (continued)
Viseven
Viseven (continued)
Viseven (continued)
ZS Associates
ZS Associates (continued)
ZS Associates (continued)
Best Practices
Growth Opportunities
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform (continued)
Significance of Being on the Frost Radar™
Frost Radar™ Empowers the CEO’s Growth Team
Frost Radar™ Empowers Investors
Frost Radar™ Empowers Customers
Frost Radar™ Empowers the Board of Directors
Next Steps
Legal Disclaimer
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform
Growth Index
Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.
-
Market Share (previous 3 years)
This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years. -
Revenue Growth (previous 3 years)
This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™. -
Growth Pipeline
This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities. -
Vision and Strategy
This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision? -
Sales and Marketing
This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.
Innovation Index
Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.
-
INNOVATION SCALABILITY
This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals. -
RESEARCH AND DEVELOPMENT
This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline. -
PRODUCT PORTFOLIO
This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue. -
MEGATRENDS LEVERAGE
This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline. -
CUSTOMER ALIGNMENT
This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.
Significance of Being on the Frost Radar™
Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.
-
GROWTH POTENTIAL
Your organization has significant future growth potential, which makes it a Company to Action. -
BEST PRACTICES
Your organization is well positioned to shape Growth Pipeline™ best practices in your industry. -
COMPETITIVE INTENSITY
Your organization is one of the key drivers of competitive intensity in the growth environment. -
CUSTOMER VALUE
Your organization has demonstrated the ability to significantly enhance its customer value proposition. -
PARTNER POTENTIAL
Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.
Speak directly with our analytics experts for tailored recommendations.
Recent related Pharmaceuticals and Biotech research
21 Jan 2025 | Global | Technology Research
Technologies Enabling Resilient Pharmaceutical Supply Chains
This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model. The study answers the following questions: What are some new challenges big pharma's supp...
16 Jan 2025 | Global | Technology Research
Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029
Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an an...
10 Sep 2024 | Global | Market Research
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market str...
10 Sep 2024 | Global | Technology Research
Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing
This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeu...
09 Sep 2024 | Global | Technology Research
AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029
This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-b...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Frost Radar |
|---|---|
| Author | Aarti Siddhesh Chitale |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Pharmaceutical Commercialization |
| Keyword 2 | Drug Marketing Solutions |
| Keyword 3 | Pharma Service Innovations |
| Podcast | No |
| WIP Number | PFP2-01-00-00-00 |